Published in Nature on February 28, 2013
Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nat Rev Microbiol (2014) 3.48
The rise of regulatory RNA. Nat Rev Genet (2014) 3.02
CRISPR-Cas systems: Prokaryotes upgrade to adaptive immunity. Mol Cell (2014) 2.87
Rapid evolution of the human gut virome. Proc Natl Acad Sci U S A (2013) 2.53
Revenge of the phages: defeating bacterial defences. Nat Rev Microbiol (2013) 2.03
Evolutionary consequences of intra-patient phage predation on microbial populations. Elife (2014) 1.78
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nat Biotechnol (2014) 1.64
MIMIVIRE is a defence system in mimivirus that confers resistance to virophage. Nature (2016) 1.50
Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat Biotechnol (2014) 1.47
A virocentric perspective on the evolution of life. Curr Opin Virol (2013) 1.29
Bacteria-phage coevolution as a driver of ecological and evolutionary processes in microbial communities. FEMS Microbiol Rev (2014) 1.22
The structural biology of CRISPR-Cas systems. Curr Opin Struct Biol (2015) 1.07
A century of the phage: past, present and future. Nat Rev Microbiol (2015) 1.05
Fitting CRISPR-associated Cas3 into the helicase family tree. Curr Opin Struct Biol (2014) 1.04
Adaptive divergence in experimental populations of Pseudomonas fluorescens. V. Insight into the niche specialist fuzzy spreader compels revision of the model Pseudomonas radiation. Genetics (2013) 1.00
CRISPR-Cas: biology, mechanisms and relevance. Philos Trans R Soc Lond B Biol Sci (2016) 0.93
Phage therapy--constraints and possibilities. Ups J Med Sci (2014) 0.92
An overview of malaria transmission from the perspective of Amazon Anopheles vectors. Mem Inst Oswaldo Cruz (2015) 0.92
CRISPR/Cas9-mediated phage resistance is not impeded by the DNA modifications of phage T4. PLoS One (2014) 0.92
Experimental evolution of pseudogenization and gene loss in a plant RNA virus. Mol Biol Evol (2013) 0.91
Evolutionary dynamics of the prokaryotic adaptive immunity system CRISPR-Cas in an explicit ecological context. J Bacteriol (2013) 0.89
Analysis of virus genomes from glacial environments reveals novel virus groups with unusual host interactions. Front Microbiol (2015) 0.89
Campylobacter jejuni acquire new host-derived CRISPR spacers when in association with bacteriophages harboring a CRISPR-like Cas4 protein. Front Microbiol (2015) 0.88
Insights into Bacteriophage Application in Controlling Vibrio Species. Front Microbiol (2016) 0.86
Phage-mediated dispersal of biofilm and distribution of bacterial virulence genes is induced by quorum sensing. PLoS Pathog (2015) 0.86
Dark Matter of the Biosphere: the Amazing World of Bacteriophage Diversity. J Virol (2015) 0.84
Bacteriophage and their potential roles in the human oral cavity. J Oral Microbiol (2015) 0.84
Bacteriophage Procurement for Therapeutic Purposes. Front Microbiol (2016) 0.82
Evolutionary Ecology of Prokaryotic Immune Mechanisms. Microbiol Mol Biol Rev (2016) 0.82
Bacteriophage behavioral ecology: How phages alter their bacterial host's habits. Bacteriophage (2014) 0.82
Complete genome sequence of 'Halanaeroarchaeum sulfurireducens' M27-SA2, a sulfur-reducing and acetate-oxidizing haloarchaeon from the deep-sea hypersaline anoxic lake Medee. Stand Genomic Sci (2016) 0.82
Functional Analysis of Bacteriophage Immunity through a Type I-E CRISPR-Cas System in Vibrio cholerae and Its Application in Bacteriophage Genome Engineering. J Bacteriol (2015) 0.82
Battling Phages: How Bacteria Defend against Viral Attack. PLoS Pathog (2015) 0.81
Viruses and mobile elements as drivers of evolutionary transitions. Philos Trans R Soc Lond B Biol Sci (2016) 0.80
RS1 satellite phage promotes diversity of toxigenic Vibrio cholerae by driving CTX prophage loss and elimination of lysogenic immunity. Infect Immun (2014) 0.80
Emerging Concepts on the Gut Microbiome and Multiple Sclerosis. J Interferon Cytokine Res (2016) 0.79
Viral coinfection is shaped by host ecology and virus-virus interactions across diverse microbial taxa and environments. Virus Evol (2017) 0.79
Acidianus Tailed Spindle Virus: a New Archaeal Large Tailed Spindle Virus Discovered by Culture-Independent Methods. J Virol (2016) 0.78
Predominance of Single Prophage Carrying a CRISPR/cas System in "Candidatus Liberibacter asiaticus" Strains in Southern China. PLoS One (2016) 0.78
Quorum Regulated Resistance of Vibrio cholerae against Environmental Bacteriophages. Sci Rep (2016) 0.78
A decade of discovery: CRISPR functions and applications. Nat Microbiol (2017) 0.77
Virology: Phages hijack a host's defence. Nature (2013) 0.77
Function of the CRISPR-Cas System of the Human Pathogen Clostridium difficile. MBio (2015) 0.77
The Bacteriophage Carrier State of Campylobacter jejuni Features Changes in Host Non-coding RNAs and the Acquisition of New Host-derived CRISPR Spacer Sequences. Front Microbiol (2016) 0.77
A genomic island in Vibrio cholerae with VPI-1 site-specific recombination characteristics contains CRISPR-Cas and type VI secretion modules. Sci Rep (2016) 0.77
Anti-cas spacers in orphan CRISPR4 arrays prevent uptake of active CRISPR-Cas I-F systems. Nat Microbiol (2016) 0.76
Comparative Analysis of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) of Streptococcus thermophilus St-I and its Bacteriophage-Insensitive Mutants (BIM) Derivatives. Curr Microbiol (2016) 0.76
CRISPR-Cas systems in the marine actinomycete Salinispora: linkages with phage defense, microdiversity and biogeography. BMC Genomics (2014) 0.76
Viruses Infecting a Freshwater Filamentous Cyanobacterium (Nostoc sp.) Encode a Functional CRISPR Array and a Proteobacterial DNA Polymerase B. MBio (2016) 0.76
Mobile DNA: an evolving field. Mob DNA (2014) 0.75
Complete genome sequence of the salmonella enterica serovar enteritidis bacteriophages fSE1C and fSE4C isolated from food matrices. Stand Genomic Sci (2017) 0.75
Phage biology: phages level the playing field. Nat Rev Microbiol (2013) 0.75
Survival and Evolution of CRISPR-Cas System in Prokaryotes and Its Applications. Front Immunol (2016) 0.75
A Review of Phage Therapy against Bacterial Pathogens of Aquatic and Terrestrial Organisms. Viruses (2017) 0.75
Bacteria vs. Bacteriophages: Parallel Evolution of Immune Arsenals. Front Microbiol (2016) 0.75
CRISPR-Cas and Contact-Dependent Secretion Systems Present on Excisable Pathogenicity Islands with Conserved Recombination Modules. J Bacteriol (2017) 0.75
To Defend or Not To Defend: That's the Question. mSphere (2016) 0.75
A cocktail of three virulent bacteriophages prevents Vibrio cholerae infection in animal models. Nat Commun (2017) 0.75
Recruitment of CRISPR-Cas systems by Tn7-like transposons. Proc Natl Acad Sci U S A (2017) 0.75
A highly specific phage defense system is a conserved feature of the Vibrio cholerae mobilome. PLoS Genet (2017) 0.75
WebLogo: a sequence logo generator. Genome Res (2004) 59.58
CRISPR provides acquired resistance against viruses in prokaryotes. Science (2007) 29.74
CRISPR/Cas, the immune system of bacteria and archaea. Science (2010) 18.72
Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol (2011) 17.11
The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature (2010) 14.21
CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science (2008) 11.82
Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology (2009) 10.67
CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation. Annu Rev Genet (2011) 9.88
The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet (2006) 8.02
CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nat Rev Genet (2010) 7.47
Bacteriophage resistance mechanisms. Nat Rev Microbiol (2010) 7.38
The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats. BMC Bioinformatics (2007) 7.34
Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence. Proc Natl Acad Sci U S A (2011) 6.89
CRISPR-based adaptive and heritable immunity in prokaryotes. Trends Biochem Sci (2009) 5.54
The CRISPR system: small RNA-guided defense in bacteria and archaea. Mol Cell (2010) 4.60
Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system. Nat Commun (2012) 4.04
The human gut virome: inter-individual variation and dynamic response to diet. Genome Res (2011) 3.32
Phage genomics: small is beautiful. Cell (2002) 3.26
CRISPR interference directs strand specific spacer acquisition. PLoS One (2012) 3.10
The phage-related chromosomal islands of Gram-positive bacteria. Nat Rev Microbiol (2010) 2.84
Self-limiting nature of seasonal cholera epidemics: Role of host-mediated amplification of phage. Proc Natl Acad Sci U S A (2005) 2.80
Cholera transmission: the host, pathogen and bacteriophage dynamic. Nat Rev Microbiol (2009) 2.79
Epidemic and endemic cholera trends over a 33-year period in Bangladesh. J Infect Dis (2002) 2.39
The phage-host arms race: shaping the evolution of microbes. Bioessays (2011) 2.27
Staphylococcal pathogenicity island interference with helper phage reproduction is a paradigm of molecular parasitism. Proc Natl Acad Sci U S A (2012) 1.35
Evidence of a dominant lineage of Vibrio cholerae-specific lytic bacteriophages shed by cholera patients over a 10-year period in Dhaka, Bangladesh. MBio (2011) 1.31
Homopolymer tail-mediated ligation PCR: a streamlined and highly efficient method for DNA cloning and library construction. Biotechniques (2013) 1.29
Genetic manipulation of Vibrio cholerae by combining natural transformation with FLP recombination. Plasmid (2010) 1.25
Phase variable O antigen biosynthetic genes control expression of the major protective antigen and bacteriophage receptor in Vibrio cholerae O1. PLoS Pathog (2012) 1.15
Reconstructing viral genomes from the environment using fosmid clones: the case of haloviruses. PLoS One (2012) 1.10
The origin of the Haitian cholera outbreak strain. N Engl J Med (2010) 9.85
Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol Microbiol (2002) 6.03
Host-induced epidemic spread of the cholera bacterium. Nature (2002) 5.20
Tn-seq: high-throughput parallel sequencing for fitness and genetic interaction studies in microorganisms. Nat Methods (2009) 4.91
Long-lived C. elegans daf-2 mutants are resistant to bacterial pathogens. Science (2003) 4.91
Roles of cyclic diguanylate in the regulation of bacterial pathogenesis. Annu Rev Microbiol (2007) 4.53
Cyclic diguanylate (c-di-GMP) regulates Vibrio cholerae biofilm formation. Mol Microbiol (2004) 4.40
Cholera. Lancet (2012) 3.80
Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun (2005) 3.13
Identification of novel factors involved in colonization and acid tolerance of Vibrio cholerae. Mol Microbiol (2002) 3.09
The EAL domain protein VieA is a cyclic diguanylate phosphodiesterase. J Biol Chem (2005) 2.92
Cyclic diguanylate regulates Vibrio cholerae virulence gene expression. Infect Immun (2005) 2.81
Cholera transmission: the host, pathogen and bacteriophage dynamic. Nat Rev Microbiol (2009) 2.79
Caenorhabditis elegans as a model host for Staphylococcus aureus pathogenesis. Infect Immun (2003) 2.59
Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh. PLoS Negl Trop Dis (2008) 2.48
The structural basis of cyclic diguanylate signal transduction by PilZ domains. EMBO J (2007) 2.39
PilZ domain proteins bind cyclic diguanylate and regulate diverse processes in Vibrio cholerae. J Biol Chem (2007) 2.31
Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis. Proc Natl Acad Sci U S A (2002) 2.29
Experimental discovery of sRNAs in Vibrio cholerae by direct cloning, 5S/tRNA depletion and parallel sequencing. Nucleic Acids Res (2009) 2.25
Transposon insertion sequencing: a new tool for systems-level analysis of microorganisms. Nat Rev Microbiol (2013) 2.22
Both chemotaxis and net motility greatly influence the infectivity of Vibrio cholerae. Proc Natl Acad Sci U S A (2004) 2.21
RrgA and RrgB are components of a multisubunit pilus encoded by the Streptococcus pneumoniae rlrA pathogenicity islet. Infect Immun (2006) 2.18
Transcriptome and phenotypic responses of Vibrio cholerae to increased cyclic di-GMP level. J Bacteriol (2006) 2.16
Catabolite control protein A (CcpA) contributes to virulence and regulation of sugar metabolism in Streptococcus pneumoniae. J Bacteriol (2005) 2.09
Live attenuated oral cholera vaccines. Expert Rev Vaccines (2006) 2.07
Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh. J Infect Dis (2004) 2.05
Diarrheal epidemics in Dhaka, Bangladesh, during three consecutive floods: 1988, 1998, and 2004. Am J Trop Med Hyg (2006) 2.02
Virulence effect of Enterococcus faecalis protease genes and the quorum-sensing locus fsr in Caenorhabditis elegans and mice. Infect Immun (2002) 1.96
Genes induced late in infection increase fitness of Vibrio cholerae after release into the environment. Cell Host Microbe (2007) 1.90
Shifting prevalence of major diarrheal pathogens in patients seeking hospital care during floods in 1998, 2004, and 2007 in Dhaka, Bangladesh. Am J Trop Med Hyg (2008) 1.90
Transcriptional regulation in the Streptococcus pneumoniae rlrA pathogenicity islet by RlrA. J Bacteriol (2003) 1.89
Relatedness of Vibrio cholerae O1/O139 isolates from patients and their household contacts, determined by multilocus variable-number tandem-repeat analysis. J Bacteriol (2010) 1.85
Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J Exp Med (2009) 1.84
A new Vibrio cholerae sRNA modulates colonization and affects release of outer membrane vesicles. Mol Microbiol (2008) 1.83
Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity. Infect Immun (2005) 1.79
Transcriptional profiling of Vibrio cholerae recovered directly from patient specimens during early and late stages of human infection. Infect Immun (2005) 1.78
Going against the grain: chemotaxis and infection in Vibrio cholerae. Nat Rev Microbiol (2005) 1.71
Strains of Escherichia coli O157:H7 differ primarily by insertions or deletions, not single-nucleotide polymorphisms. J Bacteriol (2002) 1.68
A fine scale phenotype-genotype virulence map of a bacterial pathogen. Genome Res (2012) 1.67
Isolation of Streptococcus pneumoniae biofilm mutants and their characterization during nasopharyngeal colonization. Infect Immun (2008) 1.66
Clinical outcomes in household contacts of patients with cholera in Bangladesh. Clin Infect Dis (2009) 1.61
Use of in vivo-induced antigen technology (IVIAT) to identify genes uniquely expressed during human infection with Vibrio cholerae. Proc Natl Acad Sci U S A (2003) 1.60
Cholera stool bacteria repress chemotaxis to increase infectivity. Mol Microbiol (2006) 1.60
Staphylococcal biofilm exopolysaccharide protects against Caenorhabditis elegans immune defenses. PLoS Pathog (2007) 1.58
Identification of virulence genes in a pathogenic strain of Pseudomonas aeruginosa by representational difference analysis. J Bacteriol (2002) 1.58
The Vibrio cholerae vieSAB locus encodes a pathway contributing to cholera toxin production. J Bacteriol (2002) 1.57
Listeriosis during pregnancy: a case series and review of 222 cases. Medicine (Baltimore) (2002) 1.56
Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect Immun (2009) 1.56
Identification of essential genes of the periodontal pathogen Porphyromonas gingivalis. BMC Genomics (2012) 1.55
Hyperinfectivity of human-passaged Vibrio cholerae can be modeled by growth in the infant mouse. Infect Immun (2005) 1.51
Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice. Infect Immun (2008) 1.50
Role of cyclic Di-GMP during el tor biotype Vibrio cholerae infection: characterization of the in vivo-induced cyclic Di-GMP phosphodiesterase CdpA. Infect Immun (2008) 1.47
Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1. Proc Natl Acad Sci U S A (2002) 1.47
An alternative polyamine biosynthetic pathway is widespread in bacteria and essential for biofilm formation in Vibrio cholerae. J Biol Chem (2009) 1.46
From nose to lung: the regulation behind Streptococcus pneumoniae virulence factors. Mol Microbiol (2003) 1.46
Control of virulence by small RNAs in Streptococcus pneumoniae. PLoS Pathog (2012) 1.46
Challenge of Drosophila melanogaster with Cryptococcus neoformans and role of the innate immune response. Eukaryot Cell (2004) 1.45
Galleria mellonella as a model host to study infection by the Francisella tularensis live vaccine strain. Microbes Infect (2007) 1.44
Sucrose metabolism contributes to in vivo fitness of Streptococcus pneumoniae. Mol Microbiol (2007) 1.39
Cryptococcus neoformans Kin1 protein kinase homologue, identified through a Caenorhabditis elegans screen, promotes virulence in mammals. Mol Microbiol (2004) 1.39
Natural selection in a bangladeshi population from the cholera-endemic ganges river delta. Sci Transl Med (2013) 1.39
An in vivo expression technology screen for Vibrio cholerae genes expressed in human volunteers. Proc Natl Acad Sci U S A (2007) 1.38
Growth in a biofilm induces a hyperinfectious phenotype in Vibrio cholerae. Infect Immun (2010) 1.35
Transmission of Vibrio cholerae is antagonized by lytic phage and entry into the aquatic environment. PLoS Pathog (2008) 1.34
Virulence of Staphylococcus aureus small colony variants in the Caenorhabditis elegans infection model. Infect Immun (2006) 1.34
The Enterococcus faecalis fsrB gene, a key component of the fsr quorum-sensing system, is associated with virulence in the rabbit endophthalmitis model. Infect Immun (2002) 1.33
Meeting cholera's challenge to Haiti and the world: a joint statement on cholera prevention and care. PLoS Negl Trop Dis (2011) 1.33
MgrA, an orthologue of Mga, Acts as a transcriptional repressor of the genes within the rlrA pathogenicity islet in Streptococcus pneumoniae. J Bacteriol (2003) 1.32
Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera. Infect Immun (2008) 1.32
Evidence of a dominant lineage of Vibrio cholerae-specific lytic bacteriophages shed by cholera patients over a 10-year period in Dhaka, Bangladesh. MBio (2011) 1.31
Staphylococcus aureus virulence factors identified by using a high-throughput Caenorhabditis elegans-killing model. Infect Immun (2005) 1.31
Complexity of rice-water stool from patients with Vibrio cholerae plays a role in the transmission of infectious diarrhea. Proc Natl Acad Sci U S A (2007) 1.31
In vivo expression technology. Infect Immun (2002) 1.30
Homopolymer tail-mediated ligation PCR: a streamlined and highly efficient method for DNA cloning and library construction. Biotechniques (2013) 1.29
Pneumolysin localizes to the cell wall of Streptococcus pneumoniae. J Bacteriol (2009) 1.28
The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139. Infect Immun (2004) 1.25
Acid tolerance of gastrointestinal pathogens. Curr Opin Microbiol (2002) 1.25
Roles of the sortases of Streptococcus pneumoniae in assembly of the RlrA pilus. J Bacteriol (2008) 1.25
Extracellular nucleases and extracellular DNA play important roles in Vibrio cholerae biofilm formation. Mol Microbiol (2011) 1.25
Transferable quinolone resistance in Vibrio cholerae. Antimicrob Agents Chemother (2009) 1.22
Effect of phage on the infectivity of Vibrio cholerae and emergence of genetic variants. Infect Immun (2008) 1.22
Contribution of gelatinase, serine protease, and fsr to the pathogenesis of Enterococcus faecalis endophthalmitis. Infect Immun (2004) 1.21
Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera. Clin Vaccine Immunol (2011) 1.20
Differences in gene expression between the classical and El Tor biotypes of Vibrio cholerae O1. Infect Immun (2006) 1.20
Cholera toxin-specific memory B cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1. J Infect Dis (2008) 1.18
Contribution of hemagglutinin/protease and motility to the pathogenesis of El Tor biotype cholera. Infect Immun (2006) 1.18
Cryptosporidiosis among Bangladeshi children with diarrhea: a prospective, matched, case-control study of clinical features, epidemiology and systemic antibody responses. Am J Trop Med Hyg (2004) 1.17
Immunologic responses to Vibrio cholerae in patients co-infected with intestinal parasites in Bangladesh. PLoS Negl Trop Dis (2009) 1.15
Phase variable O antigen biosynthetic genes control expression of the major protective antigen and bacteriophage receptor in Vibrio cholerae O1. PLoS Pathog (2012) 1.15
A broadening world of bacterial small RNAs. Curr Opin Microbiol (2009) 1.15